CCMH
AGIO icon

Cornerstone Capital Management Holdings’s Agios Pharmaceuticals AGIO Stock Holding History

Cornerstone Capital Management Holdings’s Portfolio AGIO Stock Details AGIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q2 		– Sell
-3,917
Closed -$159K – 1376
2016
Q1 		$159K Sell
3,917
-6,954
-64% -$297K ﹤0.01% 1247
2015
Q4 		$706K Sell
10,871
-5,579
-34% -$366K 0.01% 969
2015
Q3 		$1.16M Buy
+16,450
New +$1.61M 0.01% 846
2015
Q2 		– Sell
-900
Closed -$85K – 1405
2015
Q1 		$85K Hold
900
– – ﹤0.01% 1279
2014
Q4 		$101K Buy
+900
New +$80.4K ﹤0.01% 1160

Other funds holding AGIO

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BB
BB Biotech Schaffhausen, Switzerland $3.98B AUM 15.47% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
FV2GP
Flagship Ventures 2007 General Partner Cambridge, Massachusetts $107M AUM
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return